Stroke patients at Doncaster and Bassetlaw Teaching Hospitals (DBTH) are set to benefit from an innovative two-year pilot ...

Stroke patients at Doncaster and Bassetlaw Teaching Hospitals (DBTH) are set to benefit from an innovative two-year pilot ...

Night cramps are a problem readers often ask me about - they're a common complaint and hitherto I've been at a loss to advise ...

Dr. Hutter: Hello. Welcome to Conversations with Experts; I'm Dolph Hutter. Today we're talking about "Clopidogrel Resistance: Its Significance and Management." With me is Dr. Gilles Montalescot ...

Vascular dementia affects 150,000 people in the UK, but an early diagnosis can lead to treatment that helps slow down the ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

Explore the latest advancements in heart disease medications, including statins, beta-blockers, ACE inhibitors, and more, for improved heart health.

Jack Burgess writes about a recent medical experience which reminds his to be thankful for what he has and to those who helped.

Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...

NDAQ:HUMA) Humacyte Provides Update on Commercial Launch and Pricing of Symvess(TM) (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma ...

(Heart) For patients with coronary artery ectasia of the culprit infarct artery in acute coronary syndrome, clopidogrel (Plavix) plus rivaroxaban (Xarelto) showed mixed results compared with dual ...

Hemorrhagic stroke makes up about one-third of all stroke cases. Here, we break down: What a hemorrhagic stroke is  What's ...